Navigation Links
Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Joint Status Conference in Federal Litigations

New York, New York (PRWEB) March 30, 2013

As women in the U.S. continue to file transvaginal mesh lawsuits, Bernstein Liebhard LLP reports that the next status conference in the federal litigations underway in the U.S. District Court for the Southern District of West Virginia will be held on April 18th at 1:00 p.m. According to a calendar posted on the court’s website, this joint Status Conference will take place in four federal transvaginal mesh litigations: In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“ MDL No. 2327”). Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committees in all of these proceedings.

“We continue to hear from women who experienced the dangerous side effects of vaginal mesh. We are pleased to see these litigations moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm has filed transvaginal mesh lawsuits on behalf of hundreds of women who suffered pain, scarring, mesh erosion, infection and other side effects stemming from the surgical material. Claims pending in the four federal litigations of transvaginal mesh lawsuits were filed over products marketed by American Medical Systems, Inc., C.R. Bard, Inc., Ethicon, Inc. and Boston Scientific Corp.

Transvaginal Mesh Lawsuits
The number of lawsuits filed in the nationwide litigation surrounding transvaginal mesh has steadily increased since 2011, when the U.S. Food and Drug Administration (FDA) issued a public health alert stating there had been a five-fold increase in the amount of adverse event reports of transvaginal mesh complications filed with the agency. In the warning, the FDA also re-classified the frequency of vaginal mesh injuries stemming from pelvic organ prolapse repair as “not rare,” which was upgraded from its previous position that frequency of such complications was “rare.”*
Consolidated proceedings for transvaginal mesh lawsuits filed over products manufactured by Johnson & Johnson’s Ethicon unit and C.R. Bard are underway in New Jersey Superior Court, Atlantic County as well. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10).
In both of these litigations, Bernstein Liebhard LLP partner, Jeffrey S. Grand is serving as Co-Liaison Counsel. Earlier this month, a jury in New Jersey Superior Court awarded more than $11 million to the Plaintiff in the nation’s first trial involving an Ethicon mesh product. As part of this reward, Johnson & Johnson was ordered to pay the Plaintiff $7.76 million in punitive damages. Mr. Grand was a member of the trial team. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey (Atlantic City))

Women who allegedly suffered transvaginal mesh complications after being implanted with the surgical material may be entitled to compensation for medical expenses, pain and suffering, and other damages incurred by their injuries. A wealth of transvaginal mesh lawsuit information can be found at Bernstein Liebhard's website. Please call 1-877-779-1414 to learn more.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Transvaginal Mesh Lawyer Applauds PBS Program Questioning FDA’s Approval of Pelvic Mesh Products
2. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conferences in Federal Transvaginal Mesh Litigations
3. Vaginal Mesh Side Effect Sufferer Wins $3.35 Million Lawsuit; Transvaginal Mesh Attorney Jeff Nadrich Responds
4. US Drug Watchdog Now Urges Trial Law Firms To Join Them In A Effort To Help The Most Severely Injured Victims Of A Transvaginal Mesh Failure-With A Local Approach
5. US Drug Watchdog Now Urges Personal Injury Law Firms To Help Them Help Injured Individuals Of A Transvaginal Mesh Failure With A State Specific Approach-The Worst Victims
6. US Drug Watchdog Now Urges Top Personal Injury Trial Lawyers To Join Their State Specific Effort To Help Victims Of A Severe Transvaginal Mesh Failure To Get Compensation
7. US Drug Watchdog Now Invites Top Personal Injury Law Firms To Join Them In A State Specific Effort To Identify And Help Victims Of A Severe Transvaginal Mesh Failure
8. US Drug Watchdog Now Urges AV Rated Law Firms To Help Them Help More Victims Of A Severe Transvaginal Mesh Failure With A State Specific Approach
9. $3.35 Million Awarded in First Transvaginal Mesh Trial Verdict: Prompts Support Expansion
10. US Drug Watchdog Now Urges Trial Law Firms To Join Them In Their Effort To Help Severely Injured Victims Of A Transvaginal Mesh Failure-With A State Specific Approach
11. US Drug Watchdog Now Urges Victims Of A Transvaginal Mesh Failure To Call Them For The Names And Contacts Of Women Attorneys Who Also Have A Medical Background
Post Your Comments:
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., ... the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by ... through Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention ...
(Date:11/25/2015)... ... 25, 2015 , ... As part of a global movement ... volunteers together who want to combine talents and resources to help create sustainable ... process. The non-profit launched its first major fundraiser on November 6, 2015 at ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical ... more about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared ... thicker and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... 25, 2015 , ... Lakeview Health, a Jacksonville-based drug and ... sobriety and show through pictures what a positive difference it makes. The social ... the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short stories ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  ARKRAY USA , Inc., ... evidence demonstrating the accuracy of its blood glucose meter ... Resistance, Diabetes and Cardiovascular Disease in Los ... GLUCOCARD ® 01 meter and the Assure ® ... ability to accurately measure glucose levels in blood is ...
(Date:11/25/2015)... 25, 2015 Allergan plc (NYSE: AGN ) ... New York State Attorney General,s Office ... Act, and other statutes with the Attorney General over the ... cease marketing and selling the now generic version of memantine ... no liability, has released its counterclaims against New ...
(Date:11/25/2015)... 25, 2015 Allergan plc (NYSE: ... Rugen Therapeutics, a start-up  biotechnology company focused on ... disorders and funded by the F-Prime Biomedical Research ... into an exclusive collaboration to support the discovery ... Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
Breaking Medicine Technology: